GT BIOPHARMA INC

CUSIP: 36254L209 Class: COMMON

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 14,605 Value ($000) $4 Avg Close — Range —
Q3 2023
Shares 8,750 Value ($000) $2 Avg Close — Range —
Q2 2023
Shares 3,033 Value ($000) $1 Avg Close — Range —
Q1 2023
Shares 7,793 Value ($000) $4 Avg Close — Range —
Q4 2022
Shares 3,523 Value ($000) $3 Avg Close — Range —
Q3 2022
Shares 3,170 Value ($000) $5 Avg Close — Range —
Q2 2022
Shares 3,116 Value ($000) $9 Avg Close — Range —
Q1 2022
Shares 4,401 Value ($000) $13 Avg Close — Range —
Q4 2021
Shares 11,444 Value ($000) $34 Avg Close — Range —
Q3 2021
Shares 4,758 Value ($000) $32 Avg Close — Range —
Q2 2021
Shares 3,103 Value ($000) $48 Avg Close — Range —
Q1 2021
Shares 3,918 Value ($000) $27 Avg Close — Range —